Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Coyne Terrance P.
EVP & CFO at Royalty Pharma. Filing since 18 Jun 2020.
CIK 0001814876
Company
Date
Role
Action
Shares
Amount
Of holding
RPRX
Royalty Pharma plc
13 Aug 2026
EVP & CFO
Sold on a plan
11,002
$645.55K
100%
RPRX
Royalty Pharma plc
26 May 2026
EVP & CFO
Sold on a plan
64,399
$3.48M
100%
RPRX
Royalty Pharma plc
28 Apr 2026
EVP & CFO
Sold on a plan
34,791
$1.73M
100%
RPRX
Royalty Pharma plc
1 Apr 2026
EVP & CFO
Sold on a plan
34,791
$1.68M
51.4%
RPRX
Royalty Pharma plc
23 Mar 2026
EVP & CFO
Sold on a plan
34,791
$1.58M
44.2%
RPRX
Royalty Pharma plc
2 Mar 2026
EVP & CFO
Sold on a plan
34,791
$1.63M
43.2%
RPRX
Royalty Pharma plc
23 Feb 2026
EVP & CFO
Sold on a plan
34,791
$1.58M
42.2%
RPRX
Royalty Pharma plc
4 Feb 2026
EVP & CFO
Sold on a plan
20,163
$872.91K
46.8%
RPRX
Royalty Pharma plc
3 Feb 2026
EVP & CFO
Sold on a plan
114,954
$4.92M
82.7%
RPRX
Royalty Pharma plc
2 Feb 2026
EVP & CFO
Sold on a plan
108,424
$4.56M
78.2%
RPRX
Royalty Pharma plc
20 Jan 2026
EVP & CFO
Sold on a plan
69,582
$2.74M
65.9%
RPRX
Royalty Pharma plc
2 Jan 2026
EVP & CFO
Sold on a plan
69,582
$2.67M
63.6%
RPRX
Royalty Pharma plc
15 Dec 2025
EVP & CFO
Sold on a plan
69,582
$2.67M
61.5%
RPRX
Royalty Pharma plc
1 Dec 2025
EVP & CFO
Sold on a plan
69,582
$2.77M
59.6%
RPRX
Royalty Pharma plc
24 Nov 2025
EVP & CFO
Sold on a plan
69,582
$2.68M
57.7%
RPRX
Royalty Pharma plc
17 Nov 2025
EVP & CFO
Sold on a plan
69,594
$2.74M
56.0%
RPRX
Royalty Pharma plc
10 Aug 2023
EVP & CFO
Sold on a plan
37,500
$1.15M
4.5%
RPRX
Royalty Pharma plc
9 Aug 2023
EVP & CFO
Sold on a plan
37,500
$1.15M
4.3%
RPRX
Royalty Pharma plc
13 Jul 2023
EVP & CFO
Sold on a plan
37,500
$1.16M
4.2%
RPRX
Royalty Pharma plc
12 Jul 2023
EVP & CFO
Sold on a plan
37,500
$1.17M
4.0%
RPRX
Royalty Pharma plc
8 Nov 2022
EVP & CFO
Sold, plan not stated
24,500
$1.07M
2.5%
RPRX
Royalty Pharma plc
2 Nov 2022
EVP & CFO
Sold, plan not stated
5,500
$236.85K
0.6%
RPRX
Royalty Pharma plc
1 Aug 2022
EVP & CFO
Sold, plan not stated
30,000
$1.30M
3.0%
RPRX
Royalty Pharma plc
3 Mar 2021
EVP & CFO
Sold, plan not stated
100,000
$4.48M
33.3%
RPRX
Royalty Pharma plc
2 Mar 2021
EVP & CFO
Sold, plan not stated
100,000
$4.69M
25.0%
RPRX
Royalty Pharma plc
18 Jun 2020
EVP & CFO
Bought
1,500
$42.00K
opened
RPRX
Royalty Pharma plc
18 Jun 2020
EVP & CFO
Bought
1,450
$40.60K
opened
27 decisions on file.
